Search Results - "Maas, Roderick P.P.W.M"
-
1
The preclinical stage of spinocerebellar ataxias
Published in Neurology (07-07-2015)“…The autosomal dominant spinocerebellar ataxias (SCAs) are a heterogeneous group of degenerative diseases of the cerebellum and connected regions. The discovery…”
Get full text
Journal Article -
2
The role of the cerebellum in degenerative ataxias and essential tremor: Insights from noninvasive modulation of cerebellar activity
Published in Movement disorders (01-02-2020)“…Over the last three decades, measuring and modulating cerebellar activity and its connectivity with other brain regions has become an emerging research topic…”
Get full text
Journal Article -
3
L-Dopa in dystonia: A modern perspective
Published in Neurology (09-05-2017)“…“Every child exhibiting dystonia merits an L-dopa trial, lest the potentially treatable condition of dopa-responsive dystonia (DRD) is missed” has been a…”
Get full text
Journal Article -
4
Neuropsychiatric Symptoms in Rhombencephalosynapsis: A Clinical Report
Published in Cerebellum (London, England) (04-09-2024)“…Rhombencephalosynapsis (RES) is a hindbrain malformation characterized by a missing cerebellar vermis with apposition or fusion of the cerebellar hemispheres…”
Get full text
Journal Article -
5
Cerebellar transcranial direct current stimulation modulates timing but not acquisition of conditioned eyeblink responses in SCA3 patients
Published in Brain stimulation (01-05-2022)“…Delay eyeblink conditioning is an extensively studied motor learning paradigm that critically depends on the integrity of the cerebellum. In healthy…”
Get full text
Journal Article -
6
Inverse associations between cerebellar inhibition and motor impairment in spinocerebellar ataxia type 3
Published in Brain stimulation (01-03-2021)“…Cerebellar ataxia generally results from a lesion disrupting the corticopontocerebellar or cerebellothalamocortical tract. The cerebellar inhibition (CBI)…”
Get full text
Journal Article -
7
Cognitive Complaints and Their Impact on Daily Life in Patients with Degenerative Cerebellar Disorders
Published in Cerebellum (London, England) (01-06-2024)“…Cognitive and affective sequelae of cerebellar disease are receiving increased attention, but their actual rate of occurrence remains unclear. Complaints may…”
Get full text
Journal Article -
8
The Genetic Homogeneity of CAPOS Syndrome: Four New Patients With the c.2452G>A (p.Glu818Lys) Mutation in the ATP1A3 Gene
Published in Pediatric neurology (01-06-2016)“…Abstract Background The clinical syndrome of cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) was first described…”
Get full text
Journal Article -
9
Cathodal skin lesions in a tattoo following transcranial direct current stimulation
Published in Brain stimulation (01-03-2021)Get full text
Journal Article -
10
Author response: L-Dopa in dystonia: A modern perspective
Published in Neurology (02-01-2018)Get full text
Journal Article -
11
Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?
Published in Movement disorders (01-06-2023)Get full text
Journal Article -
12
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients
Published in Journal of neurology (01-09-2021)“…Background The cerebellar cognitive affective syndrome scale (CCAS-S) was recently developed to detect specific neuropsychological deficits in patients with…”
Get full text
Journal Article -
13
Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial
Published in Neurotherapeutics (01-07-2022)“…Repeated sessions of cerebellar anodal transcranial direct current stimulation (tDCS) have been suggested to modulate cerebellar-motor cortex (M1) connectivity…”
Get full text
Journal Article -
14
Cerebellar Transcranial Direct Current Stimulation in the Cerebellar Cognitive Affective Syndrome: A Randomized, Double‐Blind, Sham‐Controlled Trial
Published in Movement disorders (02-11-2024)“…The cerebellar cognitive affective syndrome (CCAS) encompasses cognitive and affective symptoms in patients with cerebellar disorders, for which no proven…”
Get full text
Journal Article -
15
Interindividual differences in posterior fossa morphometry affect cerebellar tDCS-induced electric field strength
Published in Clinical neurophysiology (01-09-2023)“…•Skin-cerebellum distance is the dominant factor determining cerebellar tDCS-induced electric field strength in healthy adults.•Interindividual differences in…”
Get full text
Journal Article -
16
Exploring the clinical meaningfulness of the Scale for the Assessment and Rating of Ataxia: A comparison of patient and physician perspectives at the item level
Published in Parkinsonism & related disorders (01-10-2021)“…The Scale for the Assessment and Rating of Ataxia (SARA) is commonly used as the primary outcome measure in therapeutic trials. Driven by spontaneous comments…”
Get full text
Journal Article -
17
Therapeutic Misestimation in Patients with Degenerative Ataxia: Lessons from a Randomized Controlled Trial
Published in Movement disorders (01-01-2023)“…ABSTRACT Background The absence of effective treatments may render patients with degenerative cerebellar ataxias susceptible to a placebo response, which could…”
Get full text
Journal Article -
18
Teaching Video Neuro Images : Nine syndrome in inferior paramedian pontine infarction: More than meets the eye
Published in Neurology (22-08-2017)Get full text
Journal Article -
19
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3
Published in Movement disorders (01-09-2022)“…Background Disease severity in spinocerebellar ataxia type 3 (SCA3) is commonly defined by the Scale for the Assessment and Rating of Ataxia (SARA) sum score,…”
Get full text
Journal Article -
20
The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
Published in Journal of neurology (01-08-2023)“…Objective There currently is no disease-modifying therapy for spinocerebellar ataxia type 1 (SCA1). Genetic interventions, such as RNA-based therapies, are…”
Get full text
Journal Article